Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels using a ...
Dr. Ahmed Lawan, an assistant professor in the College of Science at The University of Alabama in Huntsville (UAH), a part of ...
Abstract: The paper presents the results of the study of the effect of singlet oxygen induced by 1267 nm laser irradiation without the use of photosensitizers on the bioenergetics of rat RINm5F ...
Biotechnology and pharmaceutical sectors lead adoption, while recombinant trypsin production opens new growth opportunities worldwide.Austin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Trypsin Market Size & ...
iCenter for Paediatric Endocrinology, Diabetology, and Clinical Research, Auf Der Bult Children's Hospital, Hannover, Germany jDepartment of Endocrinology, Diabetes, and Metabolic Diseases, University ...
ANN ARBOR, Mich., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced the ...
Now, a new study by Duke University researchers reveals that when glucagon production is blocked, they can also “switch gears” to produce GLP-1 and even amp up its levels, enhancing insulin release ...
Researchers are exploring a cost-reducing pathway to produce one of the crucial building blocks in cholesterol-lowering drugs and antibiotics. Plus, news on specialty pharmacies; autoimmune drug ...
In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial [1] reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, ...
The effects of the JAK inhibitor baricitinib (Olumiant) waned after treatment was stopped among patients with new-onset type 1 diabetes, 2-year data from the phase II BANDIT trial showed. After ...
A daily pill previously shown to slow the progression of type 1 diabetes has now shown a loss of therapeutic benefit when stopped—affirming the promise of the treatment. In 2023, an Australian trial ...